Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID-AKI
2021-002505-10Phase 2Terminated
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2021
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in acute kidney failure (AKF) comparing Bovine alkaline phosphatase with Placebo (2 arms). Primary endpoint: Composite incidence of acute kidney disease at day 28 and mortality at day 90. Started Nov 2021; status: terminated.
02
Drugs
bovine intestinal alkaline phosphatase
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2021-002505-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002505-10.